Liquid biopsy consists in the quantification and qualification of circulating cell-free DNA (cfDNA) and tumor-derived DNA (ctDNA) for cancer recognition. Recently, the characterization of seminal cfDNA (scfDNA) has been reported as a possible biomarker for prostate cancer (PCa) diagnosis.
Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis / Ponti, G., Maccaferri, M., Manfredini, M., Micali, S., Torricelli, F., Milandri, R., Del Prete, C., Ciarrocchi, A., Ruini, C., Benassi, L., Bettelli, S., Kaleci, S., Ozben, T., Tomasi, A.. - In: CLINICA CHIMICA ACTA. - ISSN 0009-8981. - 497:(2019), pp. 76-80. [10.1016/j.cca.2019.07.011]
Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis
Ruini, Cristel;
2019
Abstract
Liquid biopsy consists in the quantification and qualification of circulating cell-free DNA (cfDNA) and tumor-derived DNA (ctDNA) for cancer recognition. Recently, the characterization of seminal cfDNA (scfDNA) has been reported as a possible biomarker for prostate cancer (PCa) diagnosis.| File | Dimensione | Formato | |
|---|---|---|---|
|
Ponti_postprint_Quick-Assessment_2019.pdf
accesso aperto
Tipologia:
Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza:
Creative commons
Dimensione
1.94 MB
Formato
Adobe PDF
|
1.94 MB | Adobe PDF | |
|
Ponti_Quick-Assessment_2019.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
788.91 kB
Formato
Adobe PDF
|
788.91 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
